Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant problem. Pharmacogenetics can help individualize c...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ee9c57be612740ca8986a2041b14ae6c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!